The function of protein kinase C in myocardial fibrosis.
- Author:
Li-ying WANG
1
;
Shi-jie YANG
Author Information
1. Department of Pharmacology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Cardiomegaly;
metabolism;
Fibrosis;
Humans;
Indoles;
pharmacology;
Maleimides;
pharmacology;
Matrix Metalloproteinase 9;
metabolism;
Myocardium;
pathology;
Protein Kinase C;
antagonists & inhibitors;
classification;
metabolism;
Ventricular Remodeling
- From:
Acta Pharmaceutica Sinica
2010;45(12):1467-1471
- CountryChina
- Language:Chinese
-
Abstract:
Myocardial fibrosis is the common results of the development of a variety of heart diseases which leads to extracellular matrix protein metabolic disorders and causes cardiac remodeling owing to cardiac fibroblasts proliferation, eventually results in malignant arrhythmia, heart failure, and even the occurrence of sudden cardiac death. Effective inhibition of myocardial remodeling could prevent the occurrence of sudden death. To know the protein kinase C (PKC) effective mechanism of regulation on myocardial fibrosis, a new therapeutic target for reversing myocardial remodeling might be provided.
